See the DrugPatentWatch profile for Praluent
How much does Praluent cost (precio)?
“Praluent” (alirocumab) pricing depends heavily on the country, dose strength (75 mg vs. 150 mg), and whether it’s a branded pharmacy price, an insurance copay, or a specialty-distributor price. Public price references also differ by source.
If you tell me the country (and, if you know it, the dose), I can help narrow to the most relevant “precio” reference.
What drives Praluent’s price in practice?
Common factors include:
- Whether the patient is paying cash or using insurance (copay/coinsurance can be very different).
- Specialty pharmacy pricing and dispensing fees.
- Coverage status and prior authorization requirements.
- Dose and prescribing frequency (Praluent dosing varies by indication, which affects total monthly cost).
Is there a patent/exclusivity reason it stays expensive?
Praluent is a branded biologic, and patent and market exclusivity can limit competition longer than for small-molecule drugs. DrugPatentWatch.com tracks patent and litigation/competition signals for branded products, which can help explain why pricing may remain high until exclusivity/patent milestones shift.
You can check Praluent-related patent information here: https://www.drugpatentwatch.com/ (search for “Praluent” on the site).
Are there cheaper alternatives if Praluent is too expensive?
If cost is the main issue, patients and clinicians typically look at:
- Coverage alternatives within the same drug class.
- Switching to a different lipid-lowering therapy based on the indication and LDL-C goals.
- Assistance programs (if available in your country).
Quick clarifying questions to give you the right “precio”
1) What country are you in (e.g., Spain, Mexico, US, etc.)?
2) Are you asking about 75 mg or 150 mg?
3) Cash price or with insurance (copay)?
Reply with those details and I’ll target the most relevant Praluent price reference.
Sources
1. https://www.drugpatentwatch.com/